PEXIDARTINIB vs VIMSELTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PEXIDARTINIB vs VIMSELTINIB: Safety Overview
| Metric | PEXIDARTINIB | VIMSELTINIB |
|---|---|---|
| Total FAERS Reports | 970 | 170 |
| Deaths Reported | 17 | 0 |
| Death Rate | 1.8% | N/A |
| Hospitalizations | 91 | 5 |
| Average Patient Age | 44.9 yrs | 45.6 yrs |
| % Female Patients | 63.4% | 55.4% |
| FDA Approval Date | Aug 2, 2019 | Feb 14, 2025 |
| Manufacturer | Daiichi Sankyo Inc. | Deciphera Pharmaceuticals, LLC |
| Route | ORAL | ORAL |
| Marketing Status | Discontinued | Prescription |